Guideline courses abound at Annual Meeting

Guidelines serve as decision-making and educational aids for clinical practice to support and improve quality of care. Led by the Clinical Guidelines Committee (CGC), the Academy guideline development process follows an established methodology and administrative regulations that include meticulous review and grading of the relevant scientific literature, and a multi-layer, peer-review approval process.

The goal of the guideline development process, said Karl Beutner, MD, a California dermatologist and past chair of the CGC, is to transition from the older opinion-based models to the newer, evidence-based models. While there’s a growing understanding of what evidence-based guidelines are, there is still confusion as to what they’re not.

“Evidence-based guidelines are not intended to be the sole definition of standard of care. They’re not intended to eliminate clinical judgment; they’re not intended to prevent dermatologists from customizing the care of patients to individual situations,” Dr. Beutner said, adding that guidelines are great educational resources and help identify research gaps.

A new mobile-friendly Web app based on the AAD’s clinical guidelines of care for psoriasis allows users to access best practices in the complex management of psoriasis and psoriatic arthritis from their mobile devices. Download the psoriasis app at www.aad.org/education/clinical-guidelines/aad-psoriasis-app.

At the AAD Annual Meeting in Denver, many guideline-based sessions will be offered.

Friday, March 21

  • 3:30-5: 30 p.m.: Adverse Drug Reactions: The Evidence and the Controversies (W006); David Adams, MD

Saturday, March 22

  • 10 a.m.-noon: Translating Evidence into Practice: Acne Guidelines (W008); Bethanee Schlosser, MD
  • 10 a.m.-noon: Skin Cancer and Photoprotection in Skin of Color: Recommendations for Prevention, Education and Early Diagnosis (F048); Susan Taylor, MD
  • 1-3 p.m.: Appropriate Use Criteria: Mohs Surgery (W009); Mark J. Zalla, MD

 Sunday, March 23

  • 2-5 p.m.: Translating Evidence into Practice: Psoriasis Guidelines (C016); Alan Menter MD

Monday, March 24

  • 1-3 p.m.: Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines (W020); Alan Halpern, MD
  • 3:30-5 p.m.: Research Gaps in Psoriasis: Opportunities for Future Studies and Development of New Outcome Measures for Clinical Trials (F156); Director Alice B. Gottlieb, MD, PhD; Speakers: April S. Abernethy, DO; Joel M. Gelfand, MD, MSCE; Neil J. Korman, MD, PhD; Mark Lebwohl, MD; Henry W. Lim, MD; Caitriona Ryan, MD

Return to index

Top